Donnie Gillespie has extensive experience in marketing and healthcare research, and has implemented strategies for network development and operational oversight. She has expertise in Subject Matter Expert recruiting for research analyses, industry network management, and the production and editing of industry reports and newsletters. In her current role, she is responsible for the management of the Biotechnology Industry Council (BIC), a network of global industry leaders, as well as all BioPlan operations. For projects requiring deep specialization, she leverages her extensive contacts to identify and bring in additional expertise, and also provides secondary marketing research and primary qualitative research services to support client goals.

Katrina manages primary research initiatives examining technology adoption, materials selection, and capacity trends across the industry. She creates global biomanufacturing databases, market reports, and designs and executes industry studies that translate end-user insights into actionable market intelligence for biopharma companies, CDMOs, and technology suppliers. Her research focus includes market demand, scalability, supply chain considerations, and valuation. In addition to overseeing data strategy and report development, Katrina works closely with product innovators and solution providers to assess product–market fit, competitive positioning, and commercialization pathways within the rapidly evolving biomanufacturing landscape. Her background with accelerators and her education in biomedical innovation, along with experience in biomedical commercialization and strategic consulting enables her to connect technology innovation with real-world manufacturing needs and investment trends.

Renaud is a strategic commercial leader and biopharmaceutical product development expert with 25 years of international experience. His expertise spans the full lifecycle of biologics, from early-stage development to commercialization, with a focus on cost-effective, scalable solutions. Renaud delivers strategic solutions for go-to-market strategies and M&A, driving growth, operational excellence, and competitive advantage in a complex, regulated landscape. He has played pivotal roles in driving strategic growth, fundraising, and market expansion for biopharmaceutical companies, contributing to successful acquisitions by major industry players. His leadership has advanced cutting-edge bioprocessing technologies, resulting in impactful partnerships and commercial success. Renaud has contributed to globally impactful projects with leading pharmaceutical companies and international organizations, as well as large NGOs to support the development and distribution of life-saving vaccines and biologics, helping to address critical health challenges worldwide. His dual expertise in technical innovation and commercial strategy ensures that bioprocess solutions are aligned with market needs and positioned for success.

Fran Goldstein brings demonstrated expertise in subject matter expert recruiting and networking, including strategy development and planning, team building and secondary research. Her background includes Producer, Real World Leaders and Executive Leaders Radio, and President, FSG Marketing and Sales Associates. She has an MBA in Marketing/Marketing Management, General from the George Washington University and a BA from The Newhouse School of Communication, Syracuse University.

Dr. Smita Khanna is a biopharma and healthcare market researcher/analyst, with a PhD in Biotechnology. She has extensive experience working in several key industry segments and has experience with the Council of Scientific & Industrial Research-Indian Institute of Toxicology Research (CSIR-IITR), India. Her expertise includes primary and secondary research and market analysis of healthcare and biopharma segments. She contributes to international publications and journals, and research for in-depth reports.